A Review of the Centers for Disease Control and Prevention's Guidelines for the Clinical Laboratory Diagnosis of Lyme Disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal Chiropractic Medicine

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JCM.2016.08.003PMID 27857635PMCID PMC5106438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What Is Lyme Disease?

  2025cited by this paper
• Surveillance for Lyme Disease — United States, 2008–2015

  2017cited by this paper
• Borrelia miyamotoi Disease in the Northeastern United States

  2015cited by this paper
• Concerns Regarding a New Culture Method for Borrelia burgdorferi Not Approved for the Diagnosis of Lyme Disease

  2014influential reference
• The expanding Lyme Borrelia complex--clinical significance of genomic species?

  2011cited by this paper
• Laboratory diagnostic testing for Borrelia burgdorferi infection.

  2011influential reference
• Neurologic Manifestations of Lyme Disease

  2011influential reference
• Diagnostic challenges of early Lyme disease: Lessons from a community case series

  2009cited by this paper
• Surveillance for Lyme disease--United States, 1992-2006.

  2008cited by this paper
• Clinical tests: sensitivity and specificity

  2008cited by this paper
• Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events-- United States, 2005-2006; and, Surveillance for waterborne disease and outbreaks associated with drinking water and water not intended for drinking-- United

  2008cited by this paper
• Erratum: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America (Clinical Infectious Diseases (2006) 43, (1089-1134))

  2007cited by this paper
• Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis.

  2006cited by this paper
• The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

  2006influential reference
• Borrelia spielmanii Erythema Migrans, Hungary

  2005cited by this paper
• Lyme disease.

  2001cited by this paper
• Surveillance for Lyme disease--United States, 1992-1998.

  2000influential reference
• Laboratory Evaluation in the Diagnosis of Lyme Disease

  1997cited by this paper
• Guidelines for Laboratory Evaluation in the Diagnosis of Lyme Disease

  1997cited by this paper
• Tietz Fundamentals of Clinical Chemistry

  1996cited by this paper
• Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota

  1996cited by this paper
• Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans

  1996cited by this paper
• Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

  1995cited by this paper
• Immunoblot interpretation criteria for serodiagnosis of early Lyme disease

  1995cited by this paper
• Western blotting in the serodiagnosis of Lyme disease.

  1993cited by this paper
• Lyme disease: A tick-borne spirochetosis

  1983cited by this paper
• Lyme disease-a tick-borne spirochetosis?

  1983cited by this paper
• Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.

  1977cited by this paper

• Seroprevalence of Borrelia, Anaplasma, Bartonella, Toxoplasma, Mycoplasma, Yersinia, and Chlamydia in Human Population from Eastern Poland

  2025cites this paper
• Borrelia burgdorferi Strain-Specific Differences in Mouse Infectivity and Pathology

  2025cites this paper
• Borrelia surface proteins: new horizons in Lyme disease diagnosis

  2025cites this paper
• Lyme borreliosis - review of the diagnosis and management in the multidisciplinary tick-borne disease

  2024cites this paper
• CLINICAL AND IMMUNOLOGICAL FEATURES OF REACTIVATION OF CHRONIC LYME BORRELIOSIS AFTER A PREVIOUS INFECTION OF COVID-19

  2024cites this paper
• Lyme borreliosis diagnosis: state of the art of improvements and innovations

  2023cites this paper
• Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin.

  2022cites this paper
• Clinical and serological features of Lyme borreliosis in different regions of Ukraine

  2021cites this paper
• A Fully Automated Multiplex Assay for Diagnosis of Lyme Disease with High Specificity and Improved Early Sensitivity

  2020cites this paper
• Elevated Infections of Lyme Disease Patients with Cryptosporidium parvum

  2020cites this paper
• An Update to a Review of Guidelines for the Clinical Laboratory Diagnosis of Lyme Disease.

  2020cites this paper
• Detection of a Low Level and Heterogeneous B Cell Immune Response in Peripheral Blood of Acute Borreliosis Patients With High Throughput Sequencing

  2019cites this paper
• Decoupling of Blacklegged Tick Abundance and Lyme Disease Incidence in Southern Maine, USA

  2019cites this paper
• Lyme disease: diagnosis and management

  2018cites this paper
• The Controversies, Challenges and Complexities of Lyme Disease: A Narrative Review.

  2018cites this paper
• Laboratory Investigation in CDH

  2018cites this paper
• The clinical diversity of Lyme disease – diagnostic and therapeutic challenges

  year unknowncites this paper